top of page
company description

 Transforming Respiratory Care Through Continuous Patient Insight

Clinically-validated digital biomarkers and patient monitoring for COPD, Asthma, Interstitial Lung Disease and Pulmonary Hypertension—supporting payers, pharma and healthcare leaders from R&D through to market success.

Your Digital Respiratory Partner

At electronRx, we believe the future of respiratory drug success depends on continuous patient insight. Our mission is to deliver continuous digital insights to unlock better respiratory outcomes for 454 million sufferers.

deep tech awards
deep tech awards
deep tech awards
deep tech awards
deep tech awards
deep tech awards
Award winners - deep tech
Award winners - deep tech
deep tech awards
award winner
award winner
award winner
accelerate clinical research

Accelerate Clinical Research

  • Detect exacerbations early

  • Validate digital endpoints

  • Improve trial adherence

Supported By

addenbrookes.png
papworth.png
innovate uk.png
yamaguchi clinic.png
i2.jp.png
PHA .png
EMS.png

Clinical Evidence

Every advancement at electronRx is backed by evidence. Our clinical results show how combining patient data with digital innovation accelerates respiratory drug success and delivers tangible healthcare progress.

get in touch

Get In Touch

Interested in strategic collaborations? Let’s discuss how electronRx can support your respiratory pipeline

bottom of page